Tuesday, 2 July 2019

Catalyst Biosciences Announces Oral and Poster Presentations at the International Society on Thrombosis and Haemostasis - GlobeNewswire

Catalyst Biosciences Announces Oral and Poster Presentations at the International Society on Thrombosis and Haemostasis  GlobeNewswire

Oral presentation of the final Phase 2 trial data of MarzAA for the treatment of hemophilia A or B with inhibitors. Company to host investor call and webcast on ...

No comments:

Post a Comment